24 May 2013
Keywords: fda, panel, says, darvon, risks, outweigh, benefits
Article | 23 February 2009
The analgesics Darvon (propoxyphene) and Darvocet (propoxyphene and acetaminophen), both from US drug major Eli Lilly, should be taken off
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2009
2 March 2009
16 February 2009
© 2013 thepharmaletter.com